- 全部删除
- 您的购物车当前为空
MY-5445 (N-(3-chlorophenyl)-4-phenylphthalazin-1-amine) 是特异性的 cGMP 磷酸二酯酶 PDE5抑制剂,其 Ki=1.3 μM。它是一种 ABCG2转运蛋白调节剂,具有抗增殖活性。它能抑制人血小板凝集。
为众多的药物研发团队赋能,
让新药发现更简单!
MY-5445 (N-(3-chlorophenyl)-4-phenylphthalazin-1-amine) 是特异性的 cGMP 磷酸二酯酶 PDE5抑制剂,其 Ki=1.3 μM。它是一种 ABCG2转运蛋白调节剂,具有抗增殖活性。它能抑制人血小板凝集。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 147 | In stock | |
5 mg | ¥ 386 | In stock | |
10 mg | ¥ 598 | In stock | |
25 mg | ¥ 1,170 | In stock | |
50 mg | ¥ 1,770 | In stock | |
100 mg | ¥ 2,610 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 427 | In stock |
MY-5445 相关产品
产品描述 | MY-5445 (N-(3-chlorophenyl)-4-phenylphthalazin-1-amine) is a specific inhibitor of phosphodiesterase type 5 (PDE5). MY-5445 selectively inhibits cGMP PDE (Ki:1.3 μM). |
靶点活性 | PDE5:1.3 μM (Ki), PDE5:6.7 μM , PDE4:37 μM |
体外活性 | in ABCG2-overexpressing cells, MY-5445 selectively reverses ABCG2-mediated multidrug resistance. MY-5445 reverses ABCG2-mediated multidrug resistance (MDR) by potentiating the cytotoxicity of an ABCG2 substrate drug in ABCG2-overexpressing multidrug-resistant cancer cells, possibly by modulating the function and/or the protein expression of ABCG2[2]. In the S1-M1-80 cell, MY-5445 (3 μM; 48 hours) substantially increases the topotecan-induced apoptosis[2]. |
体内活性 | I.p administration of 0.5-3 mg/kg twice a day for 15 days) produces significant relief of mechanical hypersensitivity[3]. |
别名 | N-(3-chlorophenyl)-4-phenylphthalazin-1-amine |
分子量 | 331.8 |
分子式 | C20H14ClN3 |
CAS No. | 78351-75-4 |
Smiles | Clc1cccc(Nc2nnc(-c3ccccc3)c3ccccc23)c1 |
密度 | 1.310 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 40 mg/mL (120.55 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容